CARLISLE COS INC (CSL)

US1423391002 - Common Stock

402.11  -0.17 (-0.04%)

After market: 402.93 +0.82 (+0.2%)

Fundamental Rating

7

Taking everything into account, CSL scores 7 out of 10 in our fundamental rating. CSL was compared to 40 industry peers in the Building Products industry. Both the health and profitability get an excellent rating, making CSL a very profitable company, without any liquidiy or solvency issues. CSL is not valued too expensively and it also shows a decent growth rate. This makes CSL very considerable for quality investing!



9

1. Profitability

1.1 Basic Checks

In the past year CSL was profitable.
In the past year CSL had a positive cash flow from operations.
Each year in the past 5 years CSL has been profitable.
In the past 5 years CSL always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 20.41%, CSL belongs to the top of the industry, outperforming 97.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of 45.70%, CSL belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 15.75%, CSL is doing good in the industry, outperforming 72.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CSL is in line with the industry average of 13.74%.
The 3 year average ROIC (12.27%) for CSL is below the current ROIC(15.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.41%
ROE 45.7%
ROIC 15.75%
ROA(3y)10.04%
ROA(5y)8.83%
ROE(3y)24.51%
ROE(5y)20.79%
ROIC(3y)12.27%
ROIC(5y)11.04%

1.3 Margins

Looking at the Profit Margin, with a value of 27.83%, CSL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CSL's Profit Margin has improved in the last couple of years.
CSL's Operating Margin of 23.43% is amongst the best of the industry. CSL outperforms 92.50% of its industry peers.
CSL's Operating Margin has improved in the last couple of years.
CSL's Gross Margin of 37.56% is fine compared to the rest of the industry. CSL outperforms 65.00% of its industry peers.
In the last couple of years the Gross Margin of CSL has grown nicely.
Industry RankSector Rank
OM 23.43%
PM (TTM) 27.83%
GM 37.56%
OM growth 3Y21.42%
OM growth 5Y13.53%
PM growth 3Y30.48%
PM growth 5Y4.18%
GM growth 3Y8.16%
GM growth 5Y6.32%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CSL is still creating some value.
The number of shares outstanding for CSL has been reduced compared to 1 year ago.
Compared to 5 years ago, CSL has less shares outstanding
The debt/assets ratio for CSL has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 6.01 indicates that CSL is not in any danger for bankruptcy at the moment.
CSL has a Altman-Z score of 6.01. This is in the better half of the industry: CSL outperforms 70.00% of its industry peers.
CSL has a debt to FCF ratio of 2.19. This is a good value and a sign of high solvency as CSL would need 2.19 years to pay back of all of its debts.
CSL has a Debt to FCF ratio (2.19) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.63 indicates that CSL is somewhat dependend on debt financing.
CSL has a worse Debt to Equity ratio (0.63) than 62.50% of its industry peers.
Even though the debt/equity ratio score it not favorable for CSL, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 2.19
Altman-Z 6.01
ROIC/WACC1.64
WACC9.61%

2.3 Liquidity

CSL has a Current Ratio of 2.89. This indicates that CSL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CSL (2.89) is better than 75.00% of its industry peers.
CSL has a Quick Ratio of 2.50. This indicates that CSL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.50, CSL belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 2.5

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.54% over the past year.
CSL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.03% yearly.
Looking at the last year, CSL shows a very negative growth in Revenue. The Revenue has decreased by -24.72% in the last year.
Measured over the past years, CSL shows a small growth in Revenue. The Revenue has been growing by 0.47% on average per year.
EPS 1Y (TTM)8.54%
EPS 3Y41.25%
EPS 5Y23.03%
EPS Q2Q%20.46%
Revenue 1Y (TTM)-24.72%
Revenue growth 3Y2.61%
Revenue growth 5Y0.47%
Sales Q2Q%-4.93%

3.2 Future

The Earnings Per Share is expected to grow by 14.72% on average over the next years. This is quite good.
CSL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.73% yearly.
EPS Next Y25.2%
EPS Next 2Y18.82%
EPS Next 3Y14.72%
EPS Next 5YN/A
Revenue Next Year12.74%
Revenue Next 2Y9.11%
Revenue Next 3Y7.73%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.38, the valuation of CSL can be described as rather expensive.
CSL's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.65, CSL is valued a bit cheaper.
The Price/Forward Earnings ratio is 17.16, which indicates a rather expensive current valuation of CSL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSL is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CSL to the average of the S&P500 Index (21.38), we can say CSL is valued inline with the index average.
Industry RankSector Rank
PE 21.38
Fwd PE 17.16

4.2 Price Multiples

CSL's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CSL.
Industry RankSector Rank
P/FCF 17.74
EV/EBITDA 14.46

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CSL may justify a higher PE ratio.
A more expensive valuation may be justified as CSL's earnings are expected to grow with 14.72% in the coming years.
PEG (NY)0.85
PEG (5Y)0.93
EPS Next 2Y18.82%
EPS Next 3Y14.72%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.99%, CSL is not a good candidate for dividend investing.
CSL's Dividend Yield is a higher than the industry average which is at 1.05.
With a Dividend Yield of 0.99, CSL pays less dividend than the S&P500 average, which is at 2.26.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

The dividend of CSL is nicely growing with an annual growth rate of 15.81%!
CSL has been paying a dividend for at least 10 years, so it has a reliable track record.
CSL has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.81%
Div Incr Years33
Div Non Decr Years33

5.3 Sustainability

CSL pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
The dividend of CSL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP12%
EPS Next 2Y18.82%
EPS Next 3Y14.72%

CARLISLE COS INC

NYSE:CSL (9/6/2024, 8:06:57 PM)

After market: 402.93 +0.82 (+0.2%)

402.11

-0.17 (-0.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 21.38
Fwd PE 17.16
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.85
PEG (5Y)0.93
Profitability
Industry RankSector Rank
ROA 20.41%
ROE 45.7%
ROCE
ROIC
ROICexc
ROICexgc
OM 23.43%
PM (TTM) 27.83%
GM 37.56%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.89
Quick Ratio 2.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)8.54%
EPS 3Y41.25%
EPS 5Y
EPS Q2Q%
EPS Next Y25.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.72%
Revenue growth 3Y2.61%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y